BASEL: Syngenta AG, which is in the process of being acquired by China’s state-owned China National Chemical Corp (ChemChina) for US$43 billion, reported its fifth straight quarterly decline in sales, weighed down by currency moves and weakened demand for agrochemicals in Latin America.
Revenue fell 7 percent to US$3.74 billion in the three months through last month, the Basel, Switzerland-based company said yesterday. Analysts had predicted revenue to fall to about US$3.72 billion. While ChemChina successfully wooed its target, there is lingering tension over whether the deal will get approved by US regulators.
